Premium
Two‐year drug survival of dupilumab in a large cohort of difficult‐to‐treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry
Author(s) -
Spekhorst Lotte S.,
Ariëns Lieneke F.M.,
Schaft Jorien,
Bakker Daphne S,
Kamsteeg Marijke,
Oosting Albert J.,
Ridder Ilona,
Sloeserwij Annemiek,
Romeijn Geertruida L.E.,
Graaf Marlies,
Haeck Inge,
Thijs Judith L.,
Schuttelaar Marie L.A.,
de BruinWeller Marjolein S.
Publication year - 2020
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14324
Subject(s) - dupilumab , atopic dermatitis , medicine , methotrexate , drug , cohort , dermatology , pharmacology